Abstract:figure legend Circulating noradrenaline (NA) stimulates the release of neuropeptide Y (NPY) from presynaptic sympathetic nerve terminals via activation of β‐adrenergic receptors (β‐R). This NA‐induced NPY release can be inhibited by the β‐blocker propranolol, suggesting that this mechanism, which enhances sympathoexcitation, is mediated via β‐adrenergic receptors. Cardiac disease is marked by sympathoexcitation and elevated levels of noradrenaline (NA) and cotransmitter neuropeptide Y (NPY). Increased NPY levels are associated with a greater risk of ventricular arrhythmias and mortality. Nonetheless, the factors that cause NPY release remain poorly understood. We hypothesized that circulating catecholamines might lead to NPY release from myocardial sympathetic nerve terminals via a β‐receptor‐mediated mechanism that enhances sympathoexcitation. Ventricular interstitial NA and NPY levels were measured in six Yorkshire pigs after i.v. administration of NA (1 mg) and before and after propranolol infusion (1 mg/kg). Real‐time interstitial NPY levels were measured using ventricular capacitive immunoprobes (CIs) affixed with NPY antibodies and quantified as the change in CI input current (INPY) upon binding of NPY. Interstitial NA was measured with adjacent fast‐scan cyclic voltammetry probes (INA). A left ventricular pressure catheter and continuous ECGs were used for haemodynamic recordings, and an epicardial 56‐electrode sock was used for measurements of activation recovery interval, a surrogate of action potential duration. Upon administration of NA, heart rate and left ventricular pressure increased, and activation recovery interval shortened. Notably, NA significantly increased interstitial myocardial NPY levels. After propranolol, changes in heart rate and activation recovery interval were largely mitigated. The INA increased to a similar extent post‐propranolol vs. pre‐propranolol, but changes in INPY were significantly reduced post‐propranolol. Coronary sinus plasma analyses confirmed fast‐scan cyclic voltammetry and CI findings. Hence, this study demonstrates that circulating NA induces NPY release from ventricular sympathetic nerve terminals, the mechanism for which is mediated via β‐adrenergic receptors and can be blocked by the non‐selective β‐blocker, propranolol. Key points Cardiovascular disease is characterized by sympathovagal imbalance, with increased plasma noradrenaline (NA) and neuropeptide Y (NPY) concentrations. Increased NPY levels are associated with increased ventricular arrhythmias and mortality in heart failure. Limited data are available on the specific factors that cause NPY release. In this study, fast‐scan cyclic voltammetry and capacitive immunoprobes were used to allow for real‐time in vivo measurements of interstitial myocardial neurotransmitters and neuropeptides, respectively. Using an in vivo porcine model with cardiac fast‐scan cyclic voltammetry and capacitive immunoprobes, it was shown that systemic NA can increase ventricular interstitial NPY levels, suggesting that NA induces NPY release from postganglionic sympathetic nerves. The release of NPY was blocked by administration of the non‐selective β‐blocker propranolol, suggesting that release of NPY is dependent on activation of β‐adrenergic receptors by NA.

Evidence for Histamine As a Neurotransmitter in the Cardiac Sympathetic Nervous System.

Co-localization of Histamine and Norepinephrine in Sympathetic Ganglia and Exocytosis of Endogenous Histamine from Cardiac Sympathetic Nerve Endings of Macaca Mulatto Monkey

Tonic Nmda Receptor-Mediated Inward Current In Pre-Sympathetic Pvn Neurons Is Enhanced By Heart Failure.

Alpha2 Adrenoceptors Modulate Histamine Release from Sympathetic Nerves in the Guinea Pig Vas Deferens

Macrophage migration inhibitory factor in the paraventricular nucleus plays a major role in the sympathoexcitatory response to salt.

Influence of sodium nitroprusside to histamine induced H1 effect in guinea pig ileum

Histamine H 1 and H 2 Receptor Gene and Protein Levels Are Differentially Expressed in the Hearts of Rodents and Humans

Arrhythmogenic Effect of Sympathetic Histamine in Mouse Hearts Subjected to Acute Ischemia

Histamine Elicits Neuronal Excitatory Response of Red Nucleus in the Rat Via H2 Receptors in Vitro

Excitatory Effect of Histamine on Rat Spinal Motoneurons by Activation of Both H1 and H2 Receptors in Vitro

Evoked Catecholamine Release From Sympathetic Nerve Terminals In Cardiac Slices

Haeme Oxygenase-1 and Cardiac Anaphylaxis.

Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro.

Evidence that NMDA receptors mediate the responses of putative RVLM presympathetic neurons to vagal afferent stimulation in rats.

Facilitation of Spinal Α-Motoneuron Excitability by Histamine and the Underlying Ionic Mechanisms.

Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β‐adrenergic receptors

Histamine upregulates Nav1.8 expression in primary afferent neurons via H2 receptors: involvement in neuropathic pain.

Hypothalamic Corticotrophin Releasing Hormone and Norepinephrine Contribute to Sympathoexcitation in Heart Failure

Histamine excites rat lateral vestibular nuclear neurons through activation of post-synaptic H2 receptors.

Excitatory Effect of Histamine on Neuronal Activity of Rat Cerebellar Fastigial Nucleus in Vitro

Histamine Bidirectionally Regulates the Intrinsic Excitability of Parvalbumin-Positive Neurons in the Lateral Globus Pallidus and Promotes Motor Behaviour.